SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as investors closely monitor the stock ahead of its upcoming earnings report, with community chatter focused on whether the company can overcome headwinds like tariffs and weakness in China. Options activity suggests anticipation of a significant price move post-earnings, as analysts debate the potential for a turnaround driven by new products and strategic partnerships. Sentiment is mixed, with some expressing concerns about competition and brand perception, while others see a buying opportunity based on low expectations and potential for a positive surprise.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending amid buyout rumors and private equity chatter, creating a split within the community regarding its valuation and potential. Some traders are enthusiastic about a possible acquisition, while others express skepticism, pointing to broader concerns about competition and market conditions. The stock's recent price action and options activity are also fueling speculation and debate.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending downwards, experiencing its worst day in over a year, due to increasing investor concerns over competition from prediction market platforms like Kalshi and Robinhood. The community is actively discussing the potential impact of these alternative betting markets and whether DraftKings management will address the rising competition. Some investors express concerns about DraftKings' innovation and competitive positioning in the evolving landscape of sports betting.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community anticipates a potential 'Uptober,' historically a strong month for the cryptocurrency, while also weighing the impact of a possible government shutdown. Traders are closely watching key resistance levels and the potential for short squeezes, with some analysts predicting new all-time highs. Community members are actively discussing market trends, potential catalysts, and whether to accumulate more BTC.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

BKKT is trending following the appointment of Mike Alfred to the board, sparking speculation about future growth strategies and potential partnerships. The community is actively discussing the possibility of a short squeeze and the company's strengthened financial position. Some are drawing comparisons to past runs and anticipating new all-time highs.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending amid uncertainty surrounding a potential government shutdown and its possible market impacts, with some community members anticipating a resulting dip while others believe a resolution is already priced in or that a shutdown is bullish. Sentiment appears mixed, with some traders buying puts as a hedge against downside risk, while others point to strong technicals and quarter-end dynamics potentially driving further gains. Some traders are also noting the '666' level as a possible algorthmic target.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following news of a deal with the Trump administration regarding drug pricing, including a direct-to-consumer platform and U.S. manufacturing investments. The community is discussing the potential impact on profit margins and the company's valuation, with some seeing it as a positive catalyst after a period of underperformance. Others are analyzing the details of the agreement and its long-term implications for the pharmaceutical sector.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI.X is trending as the community rallies around the token, emphasizing its brand acquisition and fresh branding. Conversations highlight the project's association with positivity and its presence within the Solana meme coin ecosystem alongside tokens like PUMP.X and UPDOG.X. Community members are actively encouraging others to add WAGMI.X to their watchlists.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as the community spreads the word about this Solana-based meme coin and its unique branding centered around a classic dad joke. Community members are actively engaging in the joke, while highlighting the token's presence on the Jupiter Strict List. Many are emphasizing the opportunity to become an UpDog millionaire by swapping $SOL.X.

Pump.fun

Pump.fun is trending as community members actively discuss its potential within the meme coin space, particularly its relationship with $WAGMI and the Solana ecosystem. Some users are focused on buybacks and supply reduction, while others express concerns about volatility. The community is closely watching price movements, anticipating potential breakouts.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36.&nbsp;The analysts&nbsp;revised their view following Baxter’s weak&nbsp;second-quarter (Q2) results, which also included a trimmed 2025 outlook and a cautious commentary on 2026 growth.Adjusted earnings for the quarter were $0.59 per share, which missed the $0.61 consensus. Revenue of $2.81 billion slightly missed the $2.82 billion estimate. Baxter’s full-year guidance was also narrowed to $2.42 to $2.52 from $2.47 to $2.55.CFO Joel Grade pointed to ongoing softness in demand for IV fluids, which are used to deliver medications or nutrients directly into a patient’s bloodstream, as a major drag on performance. "While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks."That softness stems from conservation practices implemented after Hurricane Helene damaged Baxter’s North Carolina production facility in 2024.&nbsp;While supply has since recovered, the company expects demand to remain about 20% below normal levels for the rest of 2025, which will continue to weigh on operating income and profit per share.Stifel noted that Baxter’s disappointing Q2 results, lowered full-year guidance, and 2026 outlook have left the firm “feeling that the path to reliably-consistent mid-single-digit sales growth and more-meaningful margin expansion could take longer than previously thought.”Additional pressure came from Baxter’s pharmaceuticals segment, where injectable drug sales declined 1% and anesthesia sales dropped by low double digits globally.&nbsp;The company also voluntarily halted shipments of its Novum IQ Large Volume Pump following reports of two deaths and multiple injuries.On the positive side, Baxter lowered its projected tariff impact for 2025 to $40 million, down from a previous estimate of $60 million to $70 million.Andrew Hider is set to take over as CEO in early September.On Stocktwits, retail sentiment for Baxter was ‘extremely bullish’ amid ‘high’ message volume.One user on Stocktwits&nbsp;opined that Baxter is a profitable company with potential tailwinds over the next six months.&nbsp;<stembedurl>https://stocktwits.com/Philholl/message/623509381</stembedurl>Another user said that they started a position in the stock, calling it “way oversold” following what they viewed as a minor earnings miss, adding that healthcare stocks have been under pressure lately but don’t expect that trend to last.<stembedurl>https://stocktwits.com/Dr_Van_Nostrend/message/623270580</stembedurl><a href="https://stocktwits.com/symbol/BAX">Baxter’s stock</a> has declined 25% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Baxter International logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Baxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A Rebound

Stifel warned that Baxter’s path to consistent growth and margin expansion may take longer than expected, pointing to a cautious 2026 outlook.

Equity

Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates

Baxter (BAX) delivered earnings and revenue surprises of -1.67% and -0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?

BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.

Shares of Baxter International Inc. (BAX) fell over 2% on Monday morning after the medtech company announced that it has appointed Andrew Hider as president and chief executive officer.Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), the company said. Hider has been serving as CEO of ATS, who providers automation solutions for companies including in the life sciences, food and beverage, and consumer products industries, since 2017.Prior to joining ATS, Hider served as president and CEO of the Taylor Made Group, LLC, and served in several leaderships roles at life sciences and diagnostics company Danaher Corporation.<a href="https://stocktwits.com/symbol/BAX">Baxter</a> has been without a permanent CEO since February when José E Almeida retired from his executive roles, including that of the CEO. Since then, Brent Shafer has been serving as chair and interim CEO of the company.Shafer will now transition to independent chair of the Baxter Board, the company said.In the first quarter of 2025, Baxter’s worldwide sales from continuing operations totalled about $2.63 billion, marking a growth of 5% year-on-year, after production at its North Cove manufacturing site was disrupted to the second half of 2024 following a flooding event caused by Hurricane Helene.In May, the company said that its inventory levels are restored.Net income per diluted share for the quarter came in at $0.55, on top of the company’s original guidance.The company also divested its kidney care business to investment firm Carlyle in January for $3.8 billion.On Stocktwits, retail sentiment around Baxter fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_07_at_11_19_00_AM_png_35e8069f75.webp" alt="BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits" width="628" height="64"><figcaption>BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits</figcaption></figure>BAX stock is up by about 4% this year but down by about 10% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/scott-bessent-to-meet-china-next-two-weeks/chFtFuwR5ft">Treasury Secretary Scott Bessent Says He Will Meet His Chinese Counterpart In The Next Two Weeks: ‘There Are Things For Us To Do Together’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters

Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said.

FMS Stock Likely to Gain on New Optimization Plan FME Reignite

Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Baxter International Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$22.77
Prev Close	$22.38
Open	$22.35
Dividend Yield	3.57%
50-Day Moving Average	$24.35
Beta	0.76
Avg. Volume	8.33M
PE Ratio	-84.29

52-Week High	$38.29
52-Week Low	$21.33
Market Capitalization	$11.49B
EPS (Annual)	-$1.27
Price to Book	1.57
Revenue Per Employee	$279,894.74
Enterprise Value/EBITDA	N/A

BAX
Baxter International Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BAX News

BAX Baxter International Inc.